Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e41eefe437d41c6b293dbdc3abd7297f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9cb217f83556ce2a418344c2d485415 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0688 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-545 |
filingDate |
2015-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_274df0a18053303f76b519ecdccee46f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8d66240a2407eba71816318e0e20caf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21a61cabc49842b7b0e556bcb3470763 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29fd09defc66a6f07a0b9724ead8da5b |
publicationDate |
2018-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2018264047-A1 |
titleOfInvention |
Cell culture supernatant fluid derived from lung tissue |
abstract |
The purpose of the present invention is to provide a highly safe and highly effective pharmaceutical composition and the like for the prevention and treatment of respiratory diseases. The present invention provides a pharmaceutical composition with which it is possible to effectively repair damaged lung tissue by including a cell culture supernatant fluid derived from lung tissue. The present invention also provides a method and a kit for using said culture supernatant fluid to induce differentiation into lung surfactant protein positive cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111394304-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111297907-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114181926-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111346110-A |
priorityDate |
2014-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |